Natural treatments Peyronie's disease

Peyronie's disease is a condition characterized by the formation of a thickened plaque of fibrous tissue on one side of the penis, leading to curvature, flexibility issues, and potential pain during erections. While the precise cause of Peyronie's disease remains unclear, it may occur without any obvious injury and could be related to a genetic tendency for fibrous tissue development. Natural treatments have gained attention as alternative options for managing this condition, with some proposed remedies including acetyl-L-carnitine and para-aminobenzoic acid (PABA). Research indicates that acetyl-L-carnitine has shown promise in reducing curvature and pain, while PABA may slow disease progression, though it does not eliminate existing plaque.

Additional natural treatments suggested for Peyronie's disease include vitamin E, gotu kola, l-arginine, coenzyme Q10, and Ginkgo biloba, although evidence supporting their effectiveness remains limited. Patients are also encouraged to consider lifestyle modifications, such as quitting smoking and exercising, which may support overall health and potentially alleviate symptoms. It's important for individuals to consult healthcare providers before starting any natural treatments, as some herbal supplements may interact with prescribed medications.

Full Article

DEFINITION: Treatment of the condition in which a thickened, hardened piece of tissue forms on one side of the penis.

  • PRINCIPAL PROPOSED NATURAL TREATMENTS: Acetyl-L-carnitine, para-aminobenzoic acid
  • OTHER PROPOSED NATURAL TREATMENTS: Gotu kola, vitamin E, l-arginine, coenzyme Q10, Ginkgo biloba, Collagenase clostridium histolyticum (CCH), exercises, lifestyle changes

Introduction

Peyronie’s disease is a condition in which a plaque—a thickened, hardened piece of tissue—forms on one side of the penis. If the plaque becomes large enough, it reduces the flexibility of the penis. During an erection, the less flexible part of the penis expands to a lesser extent, causing the penis to bend. Pain may also occur. Severe curvature of the penis can make intercourse difficult or even impossible.

The cause of Peyronie’s disease is unknown, but it may involve injury to the penis that causes local bleeding, which in turn leads to the formation of fibrous tissue. However, the majority of cases occur without any apparent preceding injury.

Men with Peyronie’s disease may have a generalized tendency to form fibrous tissue, as shown by a higher-than-average incidence of Dupuytren’s contracture (a condition in which fibrous tissue develops in the hands among men with Peyronie’s). The condition also appears to be partially heritable.

Treatment of Peyronie’s disease consists, first and foremost, of watchful waiting. In many cases, the disease never becomes severe enough to cause serious difficulty. Pain on erection generally decreases with time, and in some cases, the extent of curvature also decreases.

When the condition causes significant deformity, pain, or sexual dysfunction, several treatment options may be considered. These include intralesional injections, mechanical therapies such as penile traction, and surgery. Radiation therapy is no longer recommended due to limited benefit and potential adverse effects. Among available treatments, surgery remains the most definitive option for severe or stable disease but is generally reserved for advanced cases because it can lead to complications such as penile shortening, erectile dysfunction, or sensory changes.

Principal Proposed Natural Treatments

Acetyl-L-carnitine. L-carnitine is an amino acid derivative involved in cellular energy metabolism. Although the body can synthesize sufficient amounts, supplemental forms—including acetyl-L-carnitine and propionyl-L-carnitine—have been investigated for Peyronie’s disease.

A three-month double-blind study comparing acetyl-L-carnitine (1 gram per day) with tamoxifen in forty-eight men found that acetyl-L-carnitine reduced penile curvature, while tamoxifen did not.

Another study evaluated the potential benefits of combination therapy with propionic-L-carnitine and an injected medication (verapamil). In this trial, sixty men with severe Peyronie’s disease were given verapamil injections plus three months of treatment with either propionic-L-carnitine (2 grams per day) or tamoxifen. The use of propionic-L-carnitine plus verapamil significantly reduced penile curvature, plaque size, and the need for surgery, while tamoxifen plus verapamil had little effect. These studies remain preliminary, but their results are encouraging.

Paraminobenzoic acid. Para-aminobenzoic acid (PABA) has been suggested for various diseases, including Peyronie’s disease, in which abnormal fibrous tissue is involved. However, double-blind, placebo-controlled trials have been limited. One trial enrolled 103 men with Peyronie’s disease and followed them for one year. The results showed that using PABA at a dose of 3 g taken four times daily significantly slowed the progression of Peyronie’s disease; it did not, however, reduce preexisting plaque.

Other Proposed Natural Treatments

Vitamin E has also been advocated for treating Peyronie’s disease and the related condition Dupuytren’s contracture, but there is no meaningful evidence that it is effective. The herb gotu kola is used to treat various conditions in which fibrous scar tissue causes problems, so it has been advocated for Peyronie’s disease. However, there is no meaningful evidence that it is effective.

Collagenase clostridium histolyticum (CCH) is the only nonsurgical medical therapy for Peyronie’s disease supported by high-quality clinical evidence demonstrating a meaningful reduction in penile curvature and improvement in sexual function. Multiple randomized controlled trials and post-approval studies have confirmed its effectiveness in appropriately selected patients with stable disease. More recent clinical data presented at major urology conferences have further supported its safety and efficacy, including evidence that CCH may be beneficial in cases involving ventral curvature, a presentation that was previously treated more cautiously. As a result, CCH remains a cornerstone of nonsurgical management for Peyronie’s disease in contemporary clinical practice.

Several natural treatments for Peyronie’s disease based on the Indian tradition of Ayurvedic medicine—curcumin, kanchnaar guggul, and nirumbi oil—are suggested, though these remedies are based on tradition and have little basis in science. L-arginine is an amino acid that may help relax blood vessels and improve blood flow to the penis. However, it has not been directly studied for Peyronie’s disease. Similarly, Ginkgo biloba may also increase blood flow to the penis. Small studies have suggested coenzyme Q10, an antioxidant that can reduce inflammation, may decrease pain and improve penile curvature. Penile traction and applying magnesium or heat may also help. Patients with Peyronie’s disease are also advised to make lifestyle changes, such as quitting smoking, exercising, and maintaining a healthy diet.

Herbs and Supplements to Use with Caution

Various herbs and supplements may interact adversely with drugs used to treat Peyronie’s disease, so one should consult a doctor before using any herb or supplement.


Bibliography

Biagiotti, Giorgio, and Giampaolo Cavallini. “Acetyl-L-Carnitine vs. Tamoxifen in the Oral Therapy of Peyronie’s Disease.” BJU International, vol. 88, no. 1, 2001, pp. 63–67.

Brito, Joseph. “Peyronie's Disease Treatment: Nonsurgical and More.” Healthline, 8 Feb. 2021, www.healthline.com/health/peyronies-disease/peyronies-disease-treatment-options. Accessed 27 Aug. 2023.

Cavallini, Giampaolo, et al. “Oral Propionyl-L-Carnitine and Intraplaque Verapamil in the Therapy of Advanced and Resistant Peyronie’s Disease.” BJU International, vol. 89, no. 9, 2002, pp. 895–900.

Chauhan, Meenakshi. “Herbal Remedies for Peyronie's Disease, Ayurvedic Treatment - Causes, Symptoms.” Planet Ayurveda, 3 May 2019, www.planetayurveda.com/library/peyronies-disease. Accessed 27 Aug. 2023.

“Endo Announces Peyronie’s Disease Presentation at the North Central Section of the American Urological Association.” PR Newswire, 15 Oct. 2025, www.prnewswire.com/news-releases/endo-announces-peyronies-disease-presentation-at-the-north-central-section-of-the-american-urological-association-302583920.html. Accessed 24 Dec, 2025.

“Erectile Dysfunction (Holistic) – Health Information Library.” PeaceHealth, 5 June 2015, www.peacehealth.org/medical-topics/id/hn-1213000. Accessed 16 Oct. 2024.

Sood, Brittany. “Coenzyme Q10 - StatPearls.” NCBI, 30 Jan. 2024, www.ncbi.nlm.nih.gov/books/NBK531491. Accessed 16 Oct. 2024.

Stuehr, Dennis J. "Enzymes of the L-arginine to Nitric Oxide Pathway." The Journal of Nutrition, vol. 134, no. 10 Suppl, 2004, pp. 2748S-2751S, doi:10.1093/jn/134.10.2748S. Accessed 16 Oct. 2024.

Weidner, W., et al. “Potassium Paraaminobenzoate (POTABA) in the Treatment of Peyronie’s Disease.” European Urology, vol. 47, 2005, pp. 530-36.